$4.00
-0.33-7.51%
Last update: Nov 5, 6:39 PM
Annexon Inc (ANNX) Stock Price, Quote, News & History
ANNXNASDAQ
Annexon's tanruprubart showed significant and sustained functional gains in Guillain-Barré patients, meeting key Phase 3 trial endpoints.
You can purchase shares of Annexon (NASDAQ:ANNX) through any online brokerage.
Other companies in Annexon’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Annexon has a consensus price target of $17.33.
The stock price for Annexon (NASDAQ: ANNX) is $3.99 last updated November 5, 2026 at 6:39 PM EST.
There are no upcoming dividends for Annexon.
Annexon does not have any upcoming earnings scheduled.
There is no upcoming split for Annexon.
Annexon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing...
